Chapter

Balancing Weight Loss and Health Risks
The FDA and doctors navigate the potential health risks of weight loss, including heart disease and brain damage, and question if weight loss is worth the risk, or if instead, heart and brain should be left healthy. Product advertisement may have been mentioned towards the end of the transcript.
Clips
The FDA and doctors are faced with the decision of whether it is more important to get patients thin, even if it puts them at risk for heart disease, lung issues, and brain damage, or if their weight and overall health should be left alone.
09:45 - 11:25 (01:39)
Summary
The FDA and doctors are faced with the decision of whether it is more important to get patients thin, even if it puts them at risk for heart disease, lung issues, and brain damage, or if their weight and overall health should be left alone. Weight has always been correlated with cholesterol and heart disease, but if weight is only a problem because it causes these issues, then why should it be a trade-off we are willing to make?
ChapterBalancing Weight Loss and Health Risks
EpisodeFen Phen & Redux
PodcastMaintenance Phase
The Fen-Phen and Redux panic was fueled by a young woman's experience and the FDA's approval process.
11:25 - 13:03 (01:38)
Summary
The Fen-Phen and Redux panic was fueled by a young woman's experience and the FDA's approval process. The FDA advisory committee initially rejected Redux for approval, but then scheduled another meeting which conflicted with a major neuroscience conference.
ChapterBalancing Weight Loss and Health Risks
EpisodeFen Phen & Redux
PodcastMaintenance Phase
The FDA approved FinFPhen over the objections of their own staff, scientists and researchers.
13:03 - 14:52 (01:49)
Summary
The FDA approved FinFPhen over the objections of their own staff, scientists and researchers. France and England were already publicly considering taking similar drugs off the market, and the FDA scheduled the meeting on brain doctors' Super Bowl weekend.
ChapterBalancing Weight Loss and Health Risks
EpisodeFen Phen & Redux
PodcastMaintenance Phase
Drug companies prioritize customer service to their customers, even when it goes against public interest.
14:52 - 15:50 (00:57)
Summary
Drug companies prioritize customer service to their customers, even when it goes against public interest. The approval of Redux led to a massive marketing campaign, including questionable ads.